This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Patient-centred Hereditary Ovarian Cancer Prevention and Survivorship Care in Canada
Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer
Uncovering targetable interactions of ovarian cancer cells
Exploring the role of PARG in DNA repair and cancer
Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer
Implementation of patient-oriented Folate Receptor Alpha reporting
Syngeneic mouse models: tools to study immune-based treatments for ovarian cancer
Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells
Metabolic engineering of CAR-T cells to overcome immune suppression
Fallopian imaging and lavage for early-stage tubo-ovarian cancer detection
